Cancer progression in the kidney and prostate: vital roles of sphingolipids in chemotherapy

Urology. 2002 Oct;60(4):562-8. doi: 10.1016/s0090-4295(02)01755-7.
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Aged
  • Androgen Antagonists / therapeutic use
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Apoptosis / drug effects
  • Cell Division / drug effects
  • Combined Modality Therapy
  • Disease Progression
  • Glutathione / metabolism
  • Glutathione / physiology
  • Growth Substances / pharmacology
  • Growth Substances / physiology
  • Humans
  • Kidney Neoplasms / drug therapy*
  • Kidney Neoplasms / metabolism
  • Kidney Neoplasms / physiopathology*
  • Male
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / metabolism
  • Prostatic Neoplasms / physiopathology*
  • Sphingolipids / metabolism
  • Sphingolipids / physiology*
  • Testosterone / pharmacology
  • Testosterone / physiology
  • Vinblastine / therapeutic use

Substances

  • Androgen Antagonists
  • Antineoplastic Agents
  • Antineoplastic Agents, Hormonal
  • Growth Substances
  • Sphingolipids
  • Testosterone
  • Vinblastine
  • Glutathione